397 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Why Equal Weighted Mutual Funds Scoring Over Index Funds http://www.zacks.com/stock/news/254739/why-equal-weighted-mutual-funds-scoring-over-index-funds?cid=CS-ZC-FT-254739 Mar 30, 2017 - Investors interested in maintaining a diversified portfolio might consider investing in equal-weight funds.
Allergan Acne Candidate Meets Endpoints in Phase III Studies http://www.zacks.com/stock/news/254397/allergan-acne-candidate-meets-endpoints-in-phase-iii-studies?cid=CS-ZC-FT-254397 Mar 28, 2017 - Allergan plc (AGN) in collaboration with Paratek Pharmaceuticals, Inc. (PRTK) has announced positive results from two phase III studies on sarecycline
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU http://www.zacks.com/stock/news/254077/amgens-amgn-humira-biosimilar-receives-approval-in-eu?cid=CS-ZC-FT-254077 Mar 24, 2017 - Amgen, Inc. (AMGN) announced that its biosimilar version of AbbVie Inc.'s (ABBV) rheumatoid arthritis (RA) drug Humira has been approved by the European Commission (EC).
Teva Pharma Denies Rumors of Global Workforce Reduction http://www.zacks.com/stock/news/254066/teva-pharma-denies-rumors-of-global-workforce-reduction?cid=CS-ZC-FT-254066 Mar 24, 2017 - According to recent reports, Teva Pharmaceutical Industries Ltd (TEVA) is likely lay off almost 11% of its global workforce to cut costs and improve growth prospects.
AstraZeneca Stock Rising in '17: What's Working in its Favor? http://www.zacks.com/stock/news/253879/astrazeneca-stock-rising-in-17-whats-working-in-its-favor?cid=CS-ZC-FT-253879 Mar 23, 2017 - Shares of London-based pharma giant, AstraZeneca plc (AZN) have risen 13.4% this year so far, while the Zacks classified Large-Cap Pharma industry increased 6.4%.
Allergan's Restasis Now Available in Multidose Bottle in U.S. http://www.zacks.com/stock/news/253868/allergans-restasis-now-available-in-multidose-bottle-in-us?cid=CS-ZC-FT-253868 Mar 23, 2017 - Allergan plc (AGN) recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S.
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod http://www.zacks.com/stock/news/253593/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod?cid=CS-ZC-FT-253593 Mar 21, 2017 - Allergan plc (AGN) announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21.
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded http://www.zacks.com/stock/news/253183/pharma-stock-roundup-astrazenecas-lynparza-impresses-in-study-merck-drug-label-expanded?cid=CS-ZC-FT-253183 Mar 17, 2017 - Regulatory and pipeline updates from companies like AstraZeneca (AZN) and Merck were in focus this week.
Allergan (AGN) and Editas Tie Up to Treat Eye Diseases http://www.zacks.com/stock/news/252926/allergan-agn-and-editas-tie-up-to-treat-eye-diseases?cid=CS-ZC-FT-252926 Mar 15, 2017 - Allergan plc's (AGN), and Editas Medicine, Inc. (EDIT), entered into a strategic research and development agreement.
Allergan (AGN) Enters Strategic Alliance With Editas Medicine (EDIT) - Slideshow http://seekingalpha.com/article/4055538-allergan-agn-enters-strategic-alliance-editas-medicine-edit-slideshow?source=feed_sector_healthcare Mar 15, 2017 - The following slide deck was published by Allergan plc in conjunction with this event.

Pages: 1...31323334353637383940

<<<Page 36>